RxDoctor Payments Data

Chandler Todd, MD

Family Medicine · Charleston, SCNPI 1467477539

Payments from drug & device makers

$1,241in general payments, 2019–2025

Across 82 payments — averaging $15.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$250
  • Lilly USA, LLC$195
  • Amgen$132
  • Boehringer Ingelheim$105
  • Novo Nordisk$84
  • Merck$61
  • plus $415 from 14 others

What the payments were for

  • Food & beverage$1,241100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,241 in reported general payments places this provider in the 60th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$108,707
Medicare patients
255
Services billed
1,601

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin48$62,897
EliquisApixaban76$57,135
MounjaroTirzepatide22$24,351
JanuviaSitagliptin Phosphate21$24,092
OzempicSemaglutide22$23,850
FarxigaDapagliflozin Propanediol15$17,549
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$8,286
Praluent PenAlirocumab13$6,462
BelsomraSuvorexant12$5,367
Rosuvastatin Calcium230$3,099
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate12$2,870
Fluticasone-SalmeterolFluticasone Propion/Salmeterol18$2,763
Albuterol Sulfate HfaAlbuterol Sulfate65$2,456
Lantus SolostarInsulin Glargine,hum.Rec.Anlog14$2,132
Atorvastatin Calcium224$1,983

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$105$62,89748 claims
PfizerEliquis$32$57,13576 claims
MerckJanuvia, Belsomra$61$29,45933 claims
Lilly USA, LLCMounjaro, Humulin 70-30$195$25,16333 claims
Novo NordiskOzempic$84$23,85022 claims
AstraZenecaFarxiga$250$17,54915 claims
GSKTrelegy Ellipta$43$8,28613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →